4.8 Editorial Material

Stem cell competition: how speeding mutants beat the rest

期刊

EMBO JOURNAL
卷 33, 期 20, 页码 2277-2278

出版社

WILEY-BLACKWELL
DOI: 10.15252/embj.201489823

关键词

-

向作者/读者索取更多资源

How mutations lead to tumor formation is a central question in cancer research. Although cellular changes that follow the occurrence of common mutations are well characterized, much less is known about their effects on the population level. Now, two recent studies reveal in what way oncogenic aberrations alter stem cell dynamics to provide cells with an evolutionary advantage over their neighbors (Amoyel etal, ; Baker etal, ).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer

Kristiaan J. Lenos, Daniel M. Miedema, Sophie C. Lodestijn, Lisanne E. Nijman, Tom van den Bosch, Xavier Romero Ros, Filipe C. Lourenco, Maria C. Lecca, Maartje van der Heijden, Sanne M. van Neerven, Anita van Oort, Nicolas Leveille, Ronja S. Adam, Felipe de Sousa E. Melo, Joy Otten, Patrick Veerman, Guillaume Hypolite, Lianne Koens, Scott K. Lyons, Giorgio Stassi, Douglas J. Winton, Jan Paul Medema, Edward Morrissey, Maarten F. Bijlsma, Louis Vermeulen

NATURE CELL BIOLOGY (2018)

Article Biochemistry & Molecular Biology

Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer

Linjie Zhao, Wei Wang, Lian Xu, Tao Yi, Xia Zhao, Yuquan Wei, Louis Vermeulen, Ajay Goel, Shengtao Zhou, Xin Wang

ONCOGENE (2019)

Article Cell & Tissue Engineering

Single-Cell Proteomics Reveal that Quantitative Changes in Co-expressed Lineage-Specific Transcription Factors Determine Cell Fate

Carmen G. Palii, Qian Cheng, Mark A. Gillespie, Paul Shannon, Michalina Mazurczyk, Giorgio Napolitani, Nathan D. Price, Jeffrey A. Ranish, Edward Morrissey, Douglas R. Higgs, Marjorie Brand

CELL STEM CELL (2019)

Article Multidisciplinary Sciences

Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts

Maartje van der Heijden, Daniel M. Miedema, Bartlomiej Waclaw, Veronique L. Veenstra, Maria C. Lecca, Lisanne E. Nijman, Erik van Dijk, Sanne M. van Neerven, Sophie C. Lodestijn, Kristiaan J. Lenos, Nina E. de Groot, Pramudita R. Prasetyanti, Andrea Arricibita Varea, Douglas J. Winton, Jan Paul Medema, Edward Morrissey, Bauke Ylstra, Martin A. Nowak, Maarten F. Bijlsma, Louis Vermeulen

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Genetics & Heredity

Quantifying Microsatellite Mutation Rates from Intestinal Stem Cell Dynamics in Msh2-Deficient Murine Epithelium

Joseph Christopher, Ann-Sofie Thorsen, Sam Abujudeh, Filipe C. Lourenco, Richard Kemp, Paul K. Potter, Edward Morrissey, Lee Hazelwood, Douglas J. Winton

GENETICS (2019)

Article Biochemical Research Methods

A marker-independent lineage-tracing system to quantify clonal dynamics and stem cell functionality in cancer tissue

Kristiaan J. Lenos, Sophie C. Lodestijn, Scott K. Lyons, Maarten F. Bijlsma, Daniel M. Miedema, Louis Vermeulen

NATURE PROTOCOLS (2019)

Article Medicine, Research & Experimental

A mouse model for peritoneal metastases of colorectal origin recapitulates patient heterogeneity

Vivian P. Bastiaenen, Charlotte E. L. Klaver, Maartje C. S. van der Heijden, Lisanne E. Nijman, Maria C. Lecca, Pieter J. Tanis, Kristiaan J. Lenos, Louis Vermeulen

LABORATORY INVESTIGATION (2020)

Article Pathology

Associations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study

Krijn J. C. Haasnoot, Yara Backes, Leon M. G. Moons, Onno Kranenburg, Anne Trinh, Louis Vermeulen, Michael Noe, Jurriaan B. Tuynman, Anja U. G. van Lent, Rosaline van Ginneken, Cornelis A. Seldenrijk, Mihaela G. Raicu, Kari Trumpi, Inge Ubink, Anya N. Milne, Jurjen J. Boonstra, John N. Groen, Matthijs P. Schwartz, Frank H. J. Wolfhagen, Joost M. J. Geesing, Frank ter Borg, Lodewijk A. A. Brosens, Jeroen van Bergeijk, Bernhard W. M. Spanier, Wouter H. de Vos tot Nederveen Cappel, Koen Kessels, Tom C. J. Seerden, Frank P. Vleggaar, G. Johan A. Offerhaus, Peter D. Siersema, Sjoerd G. Elias, Miangela M. Lacle

MODERN PATHOLOGY (2020)

Article Cell Biology

Heterogeneity in clone dynamics within and adjacent to intestinal tumours identified by Dre-mediated lineage tracing

Ann-Sofie Thorsen, Doran Khamis, Richard Kemp, Mathilde Colombe, Filipe C. Lourenco, Edward Morrissey, Douglas Winton

Summary: This study introduces a lineage-tracing approach based on Dre recombinase activation, independent of Cre, to investigate clonal biology of the intestinal epithelium. The research reveals that many new clones within tumors rapidly become extinct, while surviving clones exhibit accelerated population growth compared to normal crypts, showing heterogeneous dynamics within intra-tumor glands.

DISEASE MODELS & MECHANISMS (2021)

Article Oncology

Intestinal region-specific Wnt signalling profiles reveal interrelation between cell identity and oncogenic pathway activity in cancer development

Ronja S. Adam, Sanne M. van Neerven, Cayetano Pleguezuelos-Manzano, Salvatore Simmini, Nicolas Leveille, Nina E. de Groot, Andrew N. Holding, Florian Markowetz, Louis Vermeulen

CANCER CELL INTERNATIONAL (2020)

Editorial Material Genetics & Heredity

Exploiting KRAS-mediated metabolic reprogramming as a therapeutic target

Sanne Bootsma, Sanne M. van Neerven, Louis Vermeulen

Summary: Half of colorectal cancers have KRAS-activating mutations, which affect cancer cells' metabolic dependencies and lead to resistance to common drugs. A new study reveals the metabolic rewiring driven by KRAS and identifies a new therapeutic target for KRAS-mutant cancers.

NATURE GENETICS (2021)

Review Oncology

Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis

Sanne ten Hoorn, Tim R. de Back, Dirkje W. Sommeijer, Louis Vermeulen

Summary: The CMS classification system has potential clinical value in predicting prognosis and treatment response in colorectal cancer (CRC) patients. In local disease, CMS4 tumors have worse overall survival, while in metastatic disease, CMS1 tumors consistently have worse survival. Adjuvant chemotherapy is most beneficial for CMS2 and CMS3 tumors in stage II and III CRC, while it is not effective in CMS4 tumors.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Review Oncology

Stem Cells in the Exocrine Pancreas during Homeostasis, Injury, and Cancer

Sophie C. Lodestijn, Sanne M. van Neerven, Louis Vermeulen, Maarten F. Bijlsma

Summary: Cell generation and renewal play essential roles in tissue development, maintenance, and regeneration. The pancreas is a dormant organ with limited regeneration capacity, and understanding the underlying mechanisms of pancreatic stem cells may provide insights into the role of cancer stem cells (CSCs) in pancreatic ductal adenocarcinoma (PDAC). Imbalance between cellular proliferation and differentiation can lead to disease initiation, particularly cancer formation.

CANCERS (2021)

Article Oncology

Primary tumour immune response and lymph node yields in colon cancer

Nikhil Lal, Dedrick Kok Hong Chan, Minn E. Ng, Louis Vermeulen, Simon James Alexander Buczacki

Summary: High lymph node (LN) yield is predictive of overall and disease-free survival in non-metastatic colon cancer. There is no association between higher LN yield and increasing nodal positivity, but it is strongly linked with gene expression changes associated with the adaptive and dendritic cell immune response, especially in node-negative cancers. These findings were validated in an independent dataset.

BRITISH JOURNAL OF CANCER (2022)

Article Chemistry, Analytical

The Effect of Dynamic, In Vivo-like Oxaliplatin on HCT116 Spheroids in a Cancer-on-Chip Model Is Representative of the Response in Xenografts

Job Komen, Sanne M. van Neerven, Elsbeth G. B. M. Bossink, Nina E. de Groot, Lisanne E. Nijman, Albert van den Berg, Louis Vermeulen, Andries D. van der Meer

Summary: The cancer xenograft model, commonly used for testing novel cancer drugs, has limitations including ethical concerns and imperfect efficacy predictions leading to high clinical attrition rates. Utilizing microfluidic cancer-on-chip models could potentially improve upon the xenograft model by reducing variation, increasing sensitivity, scalability, and incorporating human factors. These chip models were able to replicate key elements of the xenograft model and provide additional drug efficacy information.

MICROMACHINES (2022)

暂无数据